Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
6534:TPE
CH Biotech R&D Co Ltd
92,50 NT$
-0,96%
(-0,90) 1D
30 apr, 13:30:26 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6534...
Açın
93,60 NT$
High
94,00 NT$
Low
92,50 NT$
Mkt. cap
9,51 mlrd
Avg. vol.
323,84K
Volume
51,65K
Dividend
5,19%
Quarterly dividend
1,20 NT$
Ex dividend date
21 avq 2025
P/E ratio
20,57
52-wk high
123,50 NT$
52-wk low
75,10 NT$
EPS
4,50 NT$
No. of employees
22
News stories
From sources across the web
About CH Biotech R&D Co Ltd
CEO-
Employees22
Founded2013
Headquarters-
Sector-
Websitechbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
853,66 mln
420,48 mln
216,68 mln
328,38 mln
Cost of goods sold
113,01 mln
71,75 mln
44,23 mln
63,38 mln
Cost of revenue
113,01 mln
71,75 mln
44,23 mln
63,38 mln
Research and development expenses
95,37 mln
90,77 mln
121,72 mln
98,86 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154,92 mln
107,70 mln
99,03 mln
124,14 mln
Operating expense
250,29 mln
208,89 mln
221,16 mln
223,35 mln
Total operating expenses
363,29 mln
280,64 mln
265,39 mln
286,73 mln
Operating income
490,36 mln
139,83 mln
-48,71 mln
41,65 mln
Other non operating income
654,00K
1,26 mln
1,70 mln
1,73 mln
EBT including unusual items
498,90 mln
32,51 mln
-21,67 mln
59,12 mln
EBT excluding unusual items
498,83 mln
32,51 mln
-21,19 mln
59,24 mln
Income tax expense
99,60 mln
-5,16 mln
-4,69 mln
15,34 mln
Effective tax rate
19,96%
-15,88%
21,64%
25,94%
Other operating expenses
-
-
-
-
Net income
399,40 mln
37,74 mln
-16,94 mln
43,80 mln
Net profit margin
46,79%
8,97%
-7,82%
13,34%
Earnings per share
-
-
-
-
Interest and investment income
2,02 mln
2,74 mln
3,86 mln
2,72 mln
Interest expense
-3,89 mln
-4,60 mln
-4,90 mln
-3,58 mln
Net interest expenses
-1,87 mln
-1,86 mln
-1,04 mln
-853,00K
Depreciation and amortization charges
-
-
-
-
EBITDA
535,36 mln
185,67 mln
-2,48 mln
88,81 mln
Gain or loss from assets sale
-77,00K
-
478,00K
122,00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer